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Abstract
To study the L- and M-cone pathways and their interactions in patients with Best’s macular dystrophy (BMD), ERG response
thresholds were measured to stimuli which modulated exclusively the L- or the M-cones, or both in various combinations. The
ERG threshold data could be described with a vector addition model. Compared with normals, BMD patients showed generally
larger amplitudes of the L-cone driven ERGs. However, the M-cone driven ERGs were similar in amplitude but significantly
phase advanced. The data confirm our previous observations that L- and M-cone pathways can be affected differently by retinal
degeneration, despite their large physiological and biochemical similarities. © 2000 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Best’s macular dystrophy (BMD) is an autosomal
dominant, pleomorphic, retinal disease beginning early
in life. It is associated with progressive macular degen-
eration which may lead to a severe loss of visual acuity.
Funduscopically, BMD is characterised by typical ‘egg-
yolk’ macular lesions.
The pathophysiology of retinal dysfunction in BMD
is poorly understood. The primary defect is thought to
be in the retinal pigment epithelium which is function-
ally reflected by an abnormal EOG (Cross & Bard,
1974). The a- and b-waves of the Ganzfeld ERG are
reported to be normal in BMD (Krill, Morse, Potts &
Klien, 1966; Francois, 1968; Denden, 1966; Krill, 1977;
Deutmann, 1971). A severely abnormal EOG with a
largely normal standard ERG is thought to be charac-
teristic of BMD (Fishman et al., 1993). Several studies
addressed the retinal pathophysiology involved in
BMD including molecular genetics, morphologic stud-
ies and specific electrophysiological recordings.
Recently, the gene responsible for BMD has been
cloned (VMD2) and several independent disease-spe-
cific mutations have been identified (Petrukhin et al.,
1998). Consistent with the disease phenotype, the
VMD2 mRNA was heavily expressed in the retina, and
especially in the RPE cells (Petrukhin et al., 1998). The
mutation results in an alteration of a probably mem-
brane-bound protein (bestrophin) with four putative
transmembrane regions (Bakall et al., 1999). The func-
tional consequences of the bestrophin mutations, how-
ever, can neither be inferred from the changes in the
amino-acid sequences (Petrukhin et al., 1998) nor are
there other functional indications.
Light and electron microscopic evaluation from
donor eyes showed abnormalities in both the RPE and
cone photoreceptors. The study of Weingeist, Kobrin
and Watzke (1982) showed an abnormal accumulation
of lipofuscin granules within the RPE, within the
macrophages of the subretinal space, and within the
choroid. O’Gorman, Flaherty, Fishman and Berson
(1988) found an accumulation of heterogeneous mate-
rial located between Bruch’s membrane and the pig-
ment epithelium in the fovea. Foveal photoreceptor loss
was considered to be a secondary effect. In contrast,
Frangieh, Green and Fine (1982) provided evidence
that the neural retina is primarily and the RPE is
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secondarily affected, because they found fine granular
deposits in the inner segments of the degenerating
photoreceptors and in the Mueller cells. The functional
consequences of these morphological changes of the
neural retina are still unclear.
In accordance with the conclusions of Frangieh et al.
(1982), the photopic focal ERG (FERG) to uniform
flickering fields was found to be altered in BMD pa-
tients (Falsini et al., 1996), indicating that the neurosen-
sory retina of the posterior pole is involved in the early
development of the disease. It is unclear, however,
whether the neural retina is homogeneously affected by
BMD or whether some subpathways, e.g. originating in
the different cone types, are differently involved.
To detect selective changes in the pathways originat-
ing in the different cone types and to better characterise
the pathophysiology in retinal diseases, we recently
developed a method which is based on selective stimula-
tion of the long- (L-) and middle- (M-) wavelength-sen-
sitive cone pathways and the two at several ratios of L-
to M-cone contrast (Usui, Kremers, Sharpe & Zrenner,
1998a). A very similar stimulus technique has been used
by Brainard, Calderone, Nugent and Jacobs (1999).
With our method, we were able to assess the ERG
contrast gains and dynamics of the L- and M-cone
pathways and their interactions (Kremers, Usui, Scholl
& Sharpe, 1999). We found that the ERG signals
originating in the L- and in the M-cones interact with
each other through vector addition (Kremers et al.,
1999). We found that the response phases of the L- and
M-cone driven ERGs were differently affected by re-
tinitis pigmentosa (Scholl & Kremers, 2000). This indi-
cates that a degenerative disease indeed can have
different effects on the ERG pathways originating in
the different cone types. To resolve the question
whether the different pathways are differently affected
by BMD, we applied the same technique on BMD
patients. The data show that ERG thresholds can be
described by a vector addition of L- and M-cone driven
ERG signals. BMD patients generally show an in-
creased amplitude of the L-cone driven ERG combined
with a normal response phase lag; the amplitudes of the
M-cone driven ERGs do not change significantly but
the response phase is significantly advanced. The ERG
sensitivity is significantly larger compared to normal
subjects. These results indicate that different cone path-
ways are specifically altered in BMD.
2. Methods
2.1. Patients with BMD and normal subjects
Six patients (two males and four females; mean age:
32.0 years; range: 13–53 years; Table 1) with BMD
participated in the study. The diagnosis of BMD was
based on history including a detailed family and medi-
cal history, a complete ophthalmological examination
including a funduscopic evaluation by retinal biomi-
croscopy and fundus photography, visual fields and
colour vision (Lanthony Panel D 15, desaturated). All
patients underwent electrophysiological testing includ-
ing an ERG and an EOG according to the ISCEV
standard (Marmor & Zrenner, 1993, 1995). The stan-
dard ERG was obtained in five of six patients using the
Universal Testing and Analysis System – Electrophysi-
ology 2000 system (LKC Technologies, Gaithesburg,
USA); in one patient the standard ERG was measured
with the SPIRIT Ganzfeld stimulator and data-acquisi-
tion system (NICOLET Instrument Corp.). Fundus
photographs were staged according to the classification
of Fishman et al. (1993) from normal fovea, but a
pathological electrooculogram (EOG) (stage 0), over a
minimal macular pigment mottling and hypopigmenta-
tion (stage I), a typical egg-yolk vitelliform lesion (stage
II), various stages of resorption of the vitelliform lesion
(stage III), to resorption plus fibrotic- or gliotic-appear-
ing scar formation either with or without a neovascular
membrane (stage IV). Visual acuity ranged from 0.1 to
0.8 (mean: 0.6). All patients showed severely reduced
light-peak to dark-through (Arden) ratios in the EOG.
The standard ERG response amplitudes were either
normal or supernormal combined with normal or
shorter implicit times. Most BMD patients had pro-
nounced colour vision defects, either along the tri-
tanopic confusion axis (c1 and c6) or predominantly
along the deutaranopic confusion axis (c5), whereas
no axis could be determined for two patients (c2 and
c4). Patient no. 3 had normal colour vision. Clinical
details of the individual patients are summarised in
Table 1.
Twenty nine eyes of 29 normal subjects (16 males and
13 females; mean age: 29.2 years; range: 9–57 years)
served as a control. The mean age of the normal
subjects did not differ significantly from that of the
BMD patients (unpaired t-test). The normal subjects
had normal ophthalmological findings and normal
colour vision (Kremers et al., 1999). Informed consent
was obtained from all subjects after explanation of the
purpose and possible consequences of the study. This
study was conducted in accordance with the tenets of
the Declaration of Helsinki, and with the approval of
our institutional ethical committee in human
experimentation.
2.2. L:M-cone ERG recording
The method of ERG recording has been described
before (Kremers et al., 1999; Usui, Kremers, Sharpe &
Zrenner, 1998b). Briefly, the stimuli were presented on
a computer controlled monitor (BARCO CCID 121)
driven at 100 Hz by a VSG 2:3 graphics card (Cam-
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bridge Research System). The monitor subtended
124108 deg at the 10 cm viewing distance. We used
30 Hz square wave modulation of the red, green, and
blue phosphor with predefined Michelson contrasts.
The time averaged luminance of the monitor was 66
cd:m2 (40 cd:m2 for the green phosphor, 20 cd:m2 for
the red phosphor, and 6 cd:m2 for the blue phosphor).
The time averaged chromaticity in CIE (1964) large
field coordinates was: x0.3329, y0.3181. The exci-
tation in each cone type by the monitor phosphors was
calculated by multiplying the phosphor emission spec-
tra with the psychophysically based fundamentals
(Stockman, MacLeod & Johnson, 1993). The modula-
tion of cone excitation was quantified by the cone
contrast (100% (EmaxEmin):(EmaxEmin), where
Emax and Emin are the maximal and minimal cone
excitation, respectively) and defined stimulus strength
for each cone type separately. The short-wavelength-
sensitive (S-) cone were not modulated (S-cone contrast
was 0%) in any of the stimulus conditions. In the
majority of normal subjects, we measured ERG re-
sponses to 32 different stimuli: eight conditions with
different L- to M-cone contrast ratios (1:1; 1:1; 1:2;
0:1; 2:1; 2:1; 1:2: 1:0) with four contrasts at each
condition (100, 75, 50 and 25% of the maximally possi-
ble cone contrast; an L- to M-cone contrast ratio of 1:1
corresponds to an in-phase modulation of the L- and
M-cones with equal cone contrast; an L- to M-cone
contrast ratio of 1:1 corresponds to a modulation of
the two cone types in counterphase with equal cone
contrast; an L- to M-cone contrast ratio of 1:2 corre-
sponds to an in-phase modulation of the two cone types
with the M-cone contrast twice as large as the L-cone
contrast; an L- to M-cone contrast ratio of 0:1 corre-
sponds to a silent substitution of the L-cones, etc.).
Details on the results of the measurements in the nor-
mals are described elsewhere (Kremers et al., 1999,
2000; Scholl & Kremers, 2000). Here, the results are
used as a control, with which the patient data are
compared. In the BMD patients and in ten normal
subjects, we limited the measurements to the four most
important conditions with L- to M-cone contrast ratios
of 1:1, 1:0, 0:1, and 1:1.
For the normal subjects, one eye was dilated with a
mydriatic (0.5% tropicamide); in the patients, trop-
icamide (0.5%) and phenylephrine (5%) were used. Eyes
were kept light-adapted at least 10 min before ERG
recording. Corneal ERG responses were measured with
a DTL fiber electrode (Electrode Supplies, Farnham,
UK) which were positioned on the conjunctiva directly
beneath the cornea and attached with its two ends at
the lateral and nasal canthus. The reference and skin
electrodes (gold cup electrodes) were attached to the
ipsilateral temple and the forehead, respectively. The
signals were amplified and filtered between 1 and 300
Hz (Grass Instruments Co.) and sampled at 1000 Hz
with a National Instruments AT-MIO-16DE-10 data
acquisition card. ERG responses to 12 runs, each last-
ing four seconds, were averaged in each measurement.
3. Results
3.1. Amplitude data
Fig. 1 shows the ERG responses to in-phase modula-
tion of the L- and the M-cones (L:M cone contrast
ratio 1:1; 76.8% contrast in each cone type), to pure
L-cone modulation (L:M cone contrast ratio 1:0; 24.7%
L-cone contrast), to pure M-cone modulation (L:M
cone contrast ratio 0:1; 31.2% M-cone contrast), and
to counter-phase modulation of the two cone types
(L:M cone contrast ratio 1:1; 13.8% M-cone contrast
and 13.8% L-cone contrast; the negative contrast
indicating the counter-phase modulation) for a normal
subject (A, left) and a patient with BMD (B, right).
Both showed larger responses to in-phase modulation
of the L- and the M-cones than to counter-phase
modulation and to the two cone isolating stimuli. This
difference cannot be fully accounted for by the larger
cone contrast in the in-phase condition. This is indica-
tive for additive interactions between the signals origi-
nating in the two cone types. Note that the BMD
patient displays larger amplitudes at all conditions with
the exception of the M-cone isolating condition.
The ERG responses were Fourier analysed and the
ERG response amplitude and phase were defined as the
amplitude and phase of the fundamental component.
We found a linear relationship between ERG response
amplitude and cone contrast for all conditions in both
the BMD patients and the normal subjects. The slope
of the linear regression to the data is the increase in
ERG amplitude per percent cone contrast increase.
This slope was used to define the cone contrast gain
which quantifies the ERG sensitivity. The inverse of the
cone contrast gain is the threshold cone contrast in-
crease needed for a 1 mV response increase.
Fig. 2 shows the measured ERG thresholds for three
normal subjects (left column) and for three BMD pa-
tients (right column). The ellipses are fits of a model,
based on the assumption that the signals originating in
the L- and M-cones vector sum in the total ERG
response. A detailed description of the model can be
found elsewhere (Kremers et al., 1999). Briefly, we
assume that the L- and the M-cone driven ERGs have
separate cone weightings (or cone contrast gains) and
separate phases, and that the total response is simply
the addition of the two separate responses at each
instant. When the responses are expressed as vectors,
the lengths of which give the amplitudes and the angles
with the positive x-axis are equivalent to the phases, the
total response vector will then be the addition of the
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two cone response vectors. In the fits of this model to
the threshold data, there are three free parameters: the
L-cone weighting or L-cone contrast gain (AL), the
M-cone weighting or the M-cone contrast gain (AM),
and the phase difference between the L- and the M-
cone driven ERG response.
For the majority of the normal subjects and the
BMD patients, the L-cone contrast gains were larger
than the M-cone contrast gains, although there was a
considerable inter-individual variability. For one of the
normal observers in Fig. 2 (c9), the M-cone contrast
gain was actually larger than the L-cone contrast gain.
This inter-individual variability is reflected in the differ-
ent orientations of the ellipses. Recent data strongly
suggest that the inter-individual variability in L- to
M-cone weighting ratio is related to different relative
densities of L- and M-cones in the retina (Kremers et
al., 2000).
The cone weighting data were statistically analysed
with an analysis of variance (ANOVA) with subsequent
multiple comparisons (resulting in post-test Bonferroni
P-values) between subject groups and cone type. AL of
the BMD patients (mean0.468; SE0.034 mV · %
cone contrast1) was larger than AL of the normal
Fig. 1. Averaged ERG responses to in-phase modulation of the L- and the M-cones (upper row; L:M cone contrast ratio 1:1; 76.8% L-cone
contrast; 76.8% M-cone contrast), to pure L-cone modulation (second row; L:M cone contrast ratio 1:0; 24.7% L-cone contrast; 0% M-cone
contrast), to pure M-cone modulation (third row; L:M cone contrast ratio 0:1; 0% L-cone contrast; 31.2% M-cone contrast; the negative sign
indicates a 180 deg phase shift relative to a trigger pulse that synchronises the ERG data acquisition and the stimulus; this explains the 180 deg
phase shift in the responses), and to counter-phase modulation of the two cone types (lower row; L:M cone contrast ratio 1:1; 13.8% L-cone
contrast; 13.8% M-cone contrast) for a normal subject (A, left) and a patient with BMD (B, right). The displayed ERG signals are 500 ms
extracts out of 4 s traces, that are the averages of 12 runs. Observe the larger response amplitudes for all conditions with the exception of the
response to M-cone isolating stimuli in the BMD patient.
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Fig. 2. Threshold L- (y-axis) and M- (x-axis) cone contrasts in three
normal subjects (left column) and three BMD patients (right column)
for different ratios of L- to M-cone contrast. Data points in the first
and third quadrant indicate thresholds to in-phase modulation of L-
and M-cones, whereas data points in the second and fourth quadrant
indicate thresholds to counter-phase modulation of the two cone
types. Numbers indicate subject or patient number. The ellipses are
best fits of a vector addition model to the data points. There is a
considerable inter-individual variability in the ellipse orientations
caused by individually different L- and M-cone weightings. BMD
patients generally exhibit smaller thresholds than the normal observ-
ers corresponding to an overall sensitivity increase.
the increased L-cone weightings. However, the mean of
the logarithms of the L-:M-cone ratio of the normal
observers (0.48; SE0.07) and BMD patients (0.71;
SE0.21) did not differ significantly.
Owing to the large interindividual variability of L-
and M-cone weightings, neither of them can be directly
used to quantify the overall gain in ERG sensitivity in
the individual patients. We therefore quantified the gain
in sensitivity by determining the theoretically least
threshold (Fig. 4A) defined as the smallest possible
distance of the fitted ellipse to the origin. This smallest
possible distance can be obtained analytically using the
following formula:
k
AL
2AM
2 9
AM4 AL42AL2 · AM2 · (2 cos2(PLPM)1)
2 · AL · AM · cos(PLPM)
(1)
This formula gives two k values: one is the ratio
between the L- and M-cone modulation at which the
ellipse has the least distance to the origin; the other is
the ratio at which the ellipse has the largest distance to
the origin. AL and AM are the cone weightings of the L-
and M-cone driven ERGs and (PLPM) is the phase
difference between the L- and M-cone driven ERG
responses. These three parameters are obtained from
the model fits to the threshold data. The maximal
sensitivities were defined as the inverse of these least
thresholds. The mean maximal sensitivity of the BMD
patients (0.493; SE0.033 mV % cone contrast1) was
significantly larger (PB0.0001; unpaired t-test) than
that of the normal subjects (0.32090.015 mV · % cone
contrast1; Fig. 4B).
Fig. 3. Estimated amplitude data (meanSE) for the normal subjects
and the BMD patients derived from the fits of a vector addition
model to the threshold data. From the model fits, the mean L- and
M-cone weightings (AL and AM, respectively in mV · % cone
contrast1) (A, left) and the log (AL:AM) (B, right; meanSE) are
estimated. Significant differences between groups are indicated by
asterisks.
subjects (0.29390.015 mV · % cone contrast1; PB
0.001). But AM of the BMD patients (0.12790.034
mV · % cone contrast1) was not significantly different
from AM of the normal subjects (0.11290.015 mV · %
cone contrast1). In normals and BMD patients, AL
was significantly larger than AM (PB0.001 for both
groups; Fig. 3A). From the model fits, the individual L-
to M-cone weighting ratios were obtained. To perform
an unpaired t-test, we calculated the logarithms of the
L-:M-cone ratio to obtain a normal distribution. The
BMD patients were more L-cone dominated than the
normal subjects (Fig. 3B). This is in accordance with
H.P.N. Scholl et al. : Vision Research 40 (2000) 3159–3168 3165
Fig. 4. (A) Schematic drawing showing how the theoretically least threshold is defined (the point on the ellipse with the smallest distance to the
origin in the L-:M-cone space). The inverse of the least threshold is defined as the maximal sensitivity. (B) Mean maximal sensitivity for the
normal subjects and the BMD patients. The mean maximal sensitivity (error bars indicate 19SE) of the BMD patients was significantly larger
(PB0.0001) than that of the normal subjects (indicated by an asterisk above the histograms).
3.2. Phase data
From the Fourier analysis on the ERG responses to
stimuli which isolate either the L- or the M-cones, we
obtained the phases of the L- and M-cone driven
ERGs. Phase data were only considered when the re-
sponse amplitudes were large enough (\0.85 mV) to be
significantly above noise level (typically being 0.3 mV).
As has been observed previously (Usui et al., 1998b;
Wu, Burns & Elsner, 1995), the ERG response phase
lag increased linearly with decreasing cone contrast for
the normal observers within the range of used cone
contrasts (but see Usui et al. (1998b) for when low cone
contrasts are included). To correct for the influence of
cone contrast we applied an analysis of covariance
(ANCOVA) to these phase data. We assumed that the
variability in the data was influenced by four factors
(subject group — normal subjects, BMD patients —
cone type, cone contrast, and subject number as a
random effect) and that these factors could interact. It
was further assumed that there is a linear relationship
between phase lag and cone contrast. The slope of this
linear relation was calculated separately for each com-
bination of subject group and cone type. The AN-
COVA to the data of the normal observers revealed a
positive correlation (PB0.0001) with a slope of 1.617
for the phases of the L-cone driven ERG and a positive
correlation (PB0.001) with a slope of 1.161 for the
phases of the M-cone driven ERG. For the BMD
patients, there was also a positive correlation (PB
0.005) with a slope of 1.589 for the phases of the
L-cone driven ERG and a positive correlation (PB
0.05) with a slope of 1.752 for the phases of the M-cone
driven ERG.
The effect of subject group and cone type were tested
after correction for cone contrast. The contrast cor-
rected phases of the L-cone driven ERG, PL, and the
contrast corrected phases of the M-cone driven ERG,
PM, are given as means9SE. Post-tests revealed that
PL of the normal subjects (385.792.0 deg) did not
differ significantly from PM (376.793.3 deg). In the
BMD patients, on the other hand, PL (382.694.5
deg) differed significantly (PB0.01) from PM
(344.596.9 deg). PL did not differ significantly be-
tween normals and patients, whereas PM was signifi-
cantly less negative (the M-cone driven ERG signal was
phase advanced) in the BMD patients (PB0.001; Fig.
5). Previously, we concluded on the basis of largely the
same data set of normals that the difference between PL
and PM in normal subjects was significant (Kremers et
al., 1999). This seeming discrepancy is caused by the
introduction of the patient data which necessitated a
correction for multiple comparisons in the present
study. The uncorrected P value indeed confirmed our
previous conclusion.
4. Discussion
In the present study, we evaluated the function of the
L- and M-cone pathway and their interaction in the
ERG of BMD patients. We were able to obtain ERG
response thresholds to stimuli which modulated either
exclusively L-cones or M-cones or both cone types
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simultaneously (in-phase or in counter-phase). It was
possible to describe the thresholds with a vector addi-
tion model.
4.1. Amplitude data
Our data show that BMD patients have significantly
increased ERG-sensitivities and amplitudes which are
confined to the L-cone driven ERG. A similar increase
could be observed in the standard ERGs of these
patients (Table 1). The 30 Hz flicker ERG probably has
the same origins as the ERG b-wave (Bush & Sieving,
1996). Several retinal disturbances were found to ex-
hibit supernormal amplitudes of the ERG b-wave: dia-
betic retinopathy (Karpe, Kornerup & Wulfing, 1958;
Jenkins & Cartwright, 1990; Kim, Lee, Bae, Cho &
Kang, 1997), central retinal vein obstruction (Henkes,
1953; Matsui, Katsumi, Sakaue & Hirose, 1994; Gouras
& MacKay, 1992; Matsui, Katsumi, Mehta & Hirose,
1994; Sakaue, Katsumi & Hirose, 1989), hypertensive
retinopathy (Henkes, 1953), venous stasis in glaucoma
(Wulfing, 1963), and Takayasu’s disease (Kurachi, Hi-
rose & Yonemura, 1966). It has been speculated that
this enhancement of the b-wave is caused by retinal
hypoxia. Henkes showed that the PII component of the
ERG (which is the major component shaping the b-
wave) is increased initially when the oxygen pressure
falls (Henkes, 1957). In rabbits, the b-wave amplitudes
of the ERG increased with increasing levels of ischemia
(Brunette, Olivier, Galeano & Lafond, 1983). Supernor-
mal ERGs also occur in connection with increased
blood flow rates and:or pH changes in the retina
(Papst, Demant & Niemeyer, 1982; Dawis, Hofmann &
Niemeyer, 1985; Niemeyer, 1988; Winkler, 1973) which
can be other secondary effects of hypoxia.
Gouras and MacKay reported that in patients with
central retinal vein occlusion the increase of the cone
ERG was much more pronounced for L-cones than for
the M-cones, because the cone ERG response enhance-
ment increased with increasing stimulus wavelength
(Gouras & MacKay, 1992). They suggested that antag-
onistic neural interactions are altered so that specifically
the L-cone responses are enhanced. However, the orien-
tation of the threshold ellipses strongly suggests addi-
tive interactions without any sign of an antagonistic
behaviour between L- and M-cone driven ERGs. An
additive interaction was explicitly described previously
for normal subjects (Kremers et al., 1999, 2000;
Brainard et al., 1999) but not for patients with retinitis
pigmentosa (Scholl & Kremers, 2000).
4.2. Phase data
In face of the amplitude data it is surprising that the
M-cone driven ERG was phase advanced in the BMD
patients whereas the L-cone driven ERG was tempo-
rally unaltered. However, this confirms that the two
pathways are differently affected by the disease. The
decreased phase lag of the M-cone driven ERG re-
sponse with normal phases for the L-cone driven ERG
resulted in an significantly enlarged phase difference
between the two cone pathways. We observed an even
more pronounced increase in phase difference in pa-
tients with retinitis pigmentosa (Scholl & Kremers,
2000). Possibly, an increased phase difference between
the ERG responses originating in the L- and the M-
cones is a general result of degenerative retinal pro-
cesses. Furthermore, the alterations in the L- and
M-cone ERG pathways are not only important for
detecting retinal abnormalities but also to differentiate
between different types of retinal disturbances.
The standard 30 Hz flicker ERG response to white
light showed normal implicit times in five patients and
a shortened implicit time in one patient (Table 1).
Owing to the larger L-cone weighting in most individu-
als, the ERG response to white light will be dominated
by the L-cone pathway. A temporal change in the
M-cone pathway might therefore have only minor ef-
fects on the implicit time of the white light 30 Hz-flicker
response. Our method differentiates between cone type
specific pathways and is therefore more sensitive in
detecting changes in response delays.
The BMD patients showed a large range of colour
vision disturbances from normal to very pronounced
defects. The preferential confusion axis varied between
patients. Although our study shows different alterations
in the L- and M-cone pathways in BMD, colour vision
Fig. 5. Phase data (mean9SE) of the L-cone ERG response (PL) and
the M-cone response phase (PM) for the normal subjects and the
BMD patients. Phase data are corrected for cone contrast by an
ANCOVA. Significant differences are indicated by asterisks.
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defects can not be simply attributed to these alterations
(Kremers et al., 2000). Colour vision tasks like the
Lanthony Panel D 15 are mediated by the chromatic
channel. From a recent study, in which we assessed the
L:M cone ratio by psychophysical and electrophysio-
logical techniques, we concluded that the L:M cone
weighting ratios obtained with the 30 Hz flicker ERGs
is closely correlated with the cone weighting ratios in
the luminance channel but not with the cone weighting
ratios in the chromatic channel (Kremers et al., 2000).
Both the amplitude and the phase data confirm our
previous observations that the L- and M-cone pathway
can be affected differently by retinal degeneration, de-
spite the large physiological and biochemical similari-
ties between the two cone types and their
post-receptoral pathways. It remains to be determined
which pathophysiological mechanisms are responsible
for such different affections of cone pathways.
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